Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|July 1, 1988
Debrisoquin oxidation polymorphism in a Spanish populationJ Benítez, A LLerena, J Cobaleda
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1996
Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotypeA Llerena, J Cobaleda, C Martínez, et al.
Acta Psychiatrica Scandinavica|January 1, 1993
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6A Llerena, G Edman, J Cobaleda, et al.
Clinical Pharmacology and Therapeutics|December 1, 1993
Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agentsA LLerena, A G Herraíz, J Cobaleda, et al.
Semergen|May 20, 2014
[Validation of the telephone call as a method for measuring compliance to arterial hypertension treatment in Extremadura]J Espinosa-García, J Cobaleda-Polo, M González-Velasco, et al.
Fundamental & Clinical Pharmacology|July 20, 2007
Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 alleleP Dorado, E M Peñas-Lledó, A P González, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Debrisoquine oxidation phenotype during neuroleptic monotherapyE Spina, C Martines, A P Caputi, et al.
The Pharmacogenomics Journal|June 9, 2016
High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studiesM E G Naranjo, F de Andrés, A Delgado, et al.
The Pharmacogenomics Journal|August 21, 2013
Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and SpainA Llerena, M Alvarez, P Dorado, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Polymorphic oxidation of debrisoquine in lung cancer patientsJ Benítez, J M Ladero, C Jara, et al.
Pageof 2